U.S. economic sanctions against Iran have resulted in the mounting scarcity of vital health goods and services for hundreds of thousands of Iranians.

Because of fierce Republican posturing, the Obama administration has taken a hardline against Iran, perhaps following in the footsteps of his predecessor on foreign policy.

In attempts to halt Iran’s nuclear enrichment program, the U.S. has gone to great lengths to restrict foreign imports to Western nations.

The crippling effects have caused the health-care sector to contract and foreign imports to decline by 30 percent.

“Those waivers are not functioning, as they conflict with blanket restrictions on banking, as well as bans on “dual-use” chemicals which might have a military application,” according to The Guardian.

The mounting political pressure against the oil rich nation has exacerbated the tenuous environment between Iranian medical firms and Western pharmaceuticals.

As a result, nearly 100,000 Iranian patients in need of chemotherapy drugs for cancer and bloodclotting agents for haemophiliacs have to forego treatment due to pervasive uncertainty.

The lack of supply has created a vacuum for smuggled products that are highly questionable in authenticity, with many coming by donkey from far reaches of the Middle East.

U.S. sanctions against Iran show no signs of abating even as reports from the International Atomic Energy Agency (IAEA) consistently prove that Iran is not pursuing “Weapons of Mass Destruction.”

This month marks the 10th anniversary of the Iraq War of which the costs were $2.2 trillion and 190,00 lives.

We’d be remiss if we failed to learn the past while beating on the same drum of war against Iran.